Evidence map›Paper›PMID 19075005›Full record

ArticleMolecular and cellular biology2009

p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.

Arpita Ray, Melissa K James, Stéphane Larochelle, Robert P Fisher, Stacy W Blain

RetractedOpen access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 110 citations in OpenAlex.

  1. Bioactive compound combinations fromFrontiers in pharmacology · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Arpita RayProgram in Molecular and Cellular Biology, School of Graduate Studies, SUNY Downstate Medical Center, Brooklyn, New York 11203, USA.
Melissa K James
Stéphane Larochelle
Robert P Fisher
Stacy W Blain
Memorial Sloan Kettering Cancer Center · USSUNY Downstate Health Sciences University · US

Funding

The CAK Network in Metazoan Cell Cycle RegulationR01GM056985 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI FISHER, ROBERT P · 1998 to 2010
$4.3M
NIGMS NIH HHS GM056985NIGMS NIH HHS R01 GM056985
6 · The paper itself

Abstract

Cell cycle progression is regulated by cyclin-dependent kinases (cdk's), which in turn are regulated by their interactions with stoichiometric inhibitors, such as p27(Kip1). Although p27 associates with cyclin D-cyclin-dependent kinase 4 (cdk4) constitutively, whether or not it inhibits this complex is dependent on the absence or presence of a specific tyrosine phosphorylation that converts p27 from a bound inhibitor to a bound noninhibitor under different growth conditions. This phosphorylation occurs within the 3-10 helix of p27 and may dislodge the helix from cdk4's active site to allow ATP binding. Here we show that the interaction of nonphosphorylated p27 with cdk4 also prevents the activating phosphorylation of the T-loop by cyclin H-cdk7, the cdk-activating kinase (CAK). Even though the cyclin H-cdk7 complex is present and active in contact-arrested cells, p27's association with cyclin D-cdk4 prevents T-loop phosphorylation. When p27 is tyrosine phosphorylated in proliferating cells or in vitro with the tyrosine Y kinase Abl, phosphorylation of cdk4 by cyclin H-cdk7 is permitted, even without dissociation of p27. This suggests that upon release from the contact-arrested state, a temporal order for the reactivation of inactive p27-cyclin D-cdk4 complexes must exist: p27 must be Y phosphorylated first, directly permitting cyclin H-cdk7 phosphorylation of residue T172 and the consequent restoration of kinase activity. The non-Y-phosphorylated p27-cyclin D-cdk4 complex could be phosphorylated by purified Csk1, a single-subunit CAK from fission yeast, but was still inactive due to p27's occlusion of the active site. Thus, the two modes by which p27 inhibits cyclin D-cdk4 are independent and may reinforce one another to inhibit kinase activity in contact-arrested cells, while maintaining a reservoir of preformed complex that can be activated rapidly upon cell cycle reentry.

Indexed as

Amino Acid SubstitutionAnimalsCatalysisCyclin DCyclin-Dependent Kinase 4Cyclin-Dependent Kinase-Activating KinaseCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesCyclin HCyclinsEnzyme ActivationMiceMutant ProteinsPhosphoprotein PhosphatasesPhosphorylationResting Phase, Cell CycleCcnh protein, mouseCdk7 protein, mouseCyclin DCyclin-Dependent Kinase 4Cyclin-Dependent Kinase-Activating KinaseCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesCyclin HCyclinsMutant ProteinsPhosphoprotein PhosphatasesTyrosine

Identifiers

PMID19075005
PMCPMC2643810
OpenAlexW2148800878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.